See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2013_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,495,600,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 900,323,000 |
| 2 | PropertyPlantAndEquipmentNet | 165,629,000 |
| 3 | remainder_Assets | 52,008,000 |
| 4 | LiabilitiesCurrent | 360,089,000 |
| 5 | LiabilitiesNoncurrent | 123,792,000 |
| 6 | remainder_Liabilities | 158,829,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 384,678,000 |
| 9 | ResearchAndDevelopmentExpense | 222,732,000 |
| 10 | remainder_Expenses | 325,889,000 |
| 11 | remainder_Revenues | 1,134,114,000 |
| 12 | remainder_NetIncome | 54,007,000 |
| 13 | remainder_ComprehensiveNetIncome | 2,456,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,613,560,000 |
| 1 | Liabilities | 642,710,000 |
| 2 | Expenses | 933,299,000 |
| 3 | Revenues | 1,134,114,000 |
| 4 | StockholdersEquity | 1,970,850,000 |
| 5 | NetIncome | 254,822,000 |
| 6 | ComprehensiveNetIncome | 256,050,000 |
| 7 | BaseVar | 2,690,073,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.80 |
| 9 | EconomicCapitalRatio | 3.55 |
Edgar->Model Mapping
Feature Distribution
Change over Time
